Supreme Court Protects ‘Skinny Label’ Generic Drug Pathway (2)

The Supreme Court said a district court judge was right to dismiss Amarin Pharma Inc.'s infringement suit over claims its ...
The American Journal of Managed Care

Medication Adherence and Use of Generic Drug Therapies

Generic prescribing was associated with improved medication adherence in 2 of 5 study conditions, but $0 copayments were associated with improved adherence across all conditions. We analyzed 2001-2004 ...
Opinion

Treatment for millions of Americans at stake in ‘skinny label’ Supreme Court case

The Supreme Court will soon decide a case that could upend the balance built into a bipartisan law that has accelerated the launch of generic drugs and saved American patients, employers, and ...
pharmaphorum

SCOTUS backs generic firm Hikma in skinny label dispute

In a unanimous, nine-to-zero ruling, the SCOTUS judges have ruled that Hikma's generic of Amarin Pharma's Vascepa (icosapent ...